Scaffold-Oriented Asymmetric Catalysis: Conformational Modulation of Transition State Multivalency during a Catalyst-Controlled Assembly of a Pharmaceutically Relevant Atropisomer

20 December 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A new class of superbasic, bifunctional peptidyl guanidine catalysts is presented, which enable the organocatalytic, atroposelective synthesis of axially chiral quinazolinediones. Computational modeling unveiled the conformational modulation of the catalyst by a novel phenyl urea N-cap, that shape-shifts the structure into the active, folded state. A previously unanticipated noncovalent interaction involving a difluoroacetamide acting as a hybrid mono- or bidentate hydrogen bond donor emerged as a decisive control element inducing atroposelectivity. These discoveries spurred from a scaffold-oriented project inspired from a fascinating investigational BTK inhibitor featuring two stable chiral axes, and relies on a mechanistic framework that was foreign to the extant lexicon of asymmetric catalysis.

Keywords

atropisomers
asymmetric catalysis
peptides
computational catalysis

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Details of Experiments, Compounds, and Computations
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.